StockData
Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc. (RPID) stock

RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3050% below fair value
$0.74−0.00 (-0.43%)

Close on Nov 17, 2026Market cap $36.96MP/E –Yield –

Rapid Micro Biosystems operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Rapid Micro Biosystems's operating income for the twelve months ending Jun 30, 2026 was -$49.76M. For fiscal 2025 it was -$47.39M. The highest annual figure on record is -$30.54M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$47.39M–
FY2024Dec 31, 2024-$49.92M–
FY2023Dec 31, 2023-$56.56M–
FY2022Dec 31, 2022-$63.22M–
FY2021Dec 31, 2021-$47.23M–
FY2020Dec 31, 2020-$30.54M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.32M–
Q1 FY2026Mar 31, 2026-$13.85M–
Q4 FY2025Dec 31, 2025-$12.21M–
Q3 FY2025Sep 30, 2025-$11.37M–
Q2 FY2025Jun 30, 2025-$12.15M–
Q1 FY2025Mar 31, 2025-$11.66M–
Q4 FY2024Dec 31, 2024-$10.23M–
Q3 FY2024Sep 30, 2024-$12.04M–
Q2 FY2024Jun 30, 2024-$13.38M–
Q1 FY2024Mar 31, 2024-$14.27M–
Q4 FY2023Dec 31, 2023-$12.19M–
Q3 FY2023Sep 30, 2023-$14.45M–
Q2 FY2023Jun 30, 2023-$15.05M–
Q1 FY2023Mar 31, 2023-$14.87M–
Q4 FY2022Dec 31, 2022-$17.26M–
Q3 FY2022Sep 30, 2022-$16.89M–
Q2 FY2022Jun 30, 2022-$14.07M–
Q1 FY2022Mar 31, 2022-$15.00M–
Q4 FY2021Dec 31, 2021-$14.56M–
Q3 FY2021Sep 30, 2021-$12.12M–
Q2 FY2021Jun 30, 2021-$10.86M–
Q1 FY2021Mar 31, 2021-$9.69M–
Q4 FY2020Dec 31, 2020-$9.72M–
Q3 FY2020Sep 30, 2020-$7.58M–
Q2 FY2020Jun 30, 2020-$6.01M–

More Rapid Micro Biosystems figures

See a number that looks wrong?